|
Suven Life Sciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
3885.03 Cr.
|
P/BV
|
35.02
|
Book Value (Rs.)
|
4.88
|
|
52 Week High/Low (Rs.)
|
300/103
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
02/08/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | -160.75 | -106.08 | -118.27 | -122.00 | -77.47 |
| | | | | | |
| Net CashFlow From Operating Activities | -154.10 | -115.47 | -103.15 | -127.54 | -96.02 |
| Net Cash Used In Investing Activities | 154.95 | 94.44 | -260.65 | -22.23 | 55.84 |
| Net Cash Used From Financing Activities | -0.76 | -1.05 | 395.54 | 145.69 | 34.86 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.09 | -22.09 | 31.75 | -4.07 | -5.33 |
| Cash And Cash Equivalents Begin of Year | 14.93 | 37.02 | 5.27 | 9.35 | 14.68 |
| Cash And Cash Equivalents End Of Year | 15.03 | 14.93 | 37.02 | 5.27 | 9.35 |
